Foundayo® is a needle-free, FDA-approved GLP-1 pill with an average of 12.4%† body-weight loss. If prescribed, Foundayo® is shipped directly to your door in just a few days.
Weight-loss treatment doesn’t have to involve injections. Oral options offer another way to approach medical weight management, without adding a weekly shot to your routine.
Across all Shed programs, members have seen what's possible with the right medication, personalized care, and ongoing support.
























About 2 minutes • 100% online • No appointment required
Figures are based on self-reported data. Percentages of average weight loss are from VIP member data, while total pounds lost reflect self-reported data from all members. Results may vary. Some states may require virtual appointment.

Orforglipron is the active ingredient in Foundayo®, an FDA-approved, once-daily oral GLP-1 receptor agonist. It works by activating GLP-1 receptors involved in appetite regulation, helping reduce food intake and support weight management.

Activates GLP-1 receptors that play a role in hunger and food intake.
Works on pathways involved in appetite, helping you feel satisfied with less food.
A once-daily pill that can be taken at any time of day, with or without food. No injections needed.

GLP-1 is a hormone that helps regulate appetite and food intake. Foundayo® (orforglipron) is a GLP-1 receptor agonist taken by mouth, made to support appetite control, reduced cravings, and healthy metabolic function.
Enter your current weight to see what different percentages of body-weight loss could mean in pounds.

Answer a few questions about your health history and goals.

A licensed medical provider reviews your answers and determines if Foundayo® is a good fit for you.

If prescribed, your medication is filled by a third-party dispensing pharmacy and delivered with clear instructions.

Unlimited provider follow-ups and support from your Member Success Team.
Everyone responds differently, but Foundayo® is typically introduced gradually while your provider monitors your progress and adjusts your treatment plan as needed.





Your Shed program connects you with professionals who can support different parts of your weight-loss journey.
Shed connects eligible members with licensed medical providers and trusted pharmacy partners through a secure online treatment experience.


†Weight loss results based on ATTAIN-1 Phase 3 clinical trial data for participants taking the highest dose who completed 72 weeks of treatment with a reduced-calorie diet and increased physical activity. Source: Foundayo Prescribing Information. Lilly USA, LLC, 2026. *Shed member statistics reflect members across all Shed programs and are not specific to Foundayo®. 9.8% average weight loss is from self-reported Shed member data, and total pounds lost reflects self-reported data from all members. Member photos show Shed members across all programs. Foundayo® pricing starts at $149/month for new patients using cash pay. Price does not include the $125 Shed membership and provider fee, paid directly to Shed. Medication costs are paid separately to the dispensing pharmacy. Foundayo® is FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition. Results vary by individual and are not guaranteed. Weight loss depends on factors such as diet, exercise, adherence, medical history, and individual response. Providers may evaluate patients and prescribe Foundayo® when clinically appropriate. Prescriptions are based on a medical evaluation and are at the provider's discretion. Shed is not a pharmacy and does not dispense medications. Prescriptions are fulfilled and shipped by a third-party dispensing pharmacy. Medications carry risks and side effects. Patients should review the full Prescribing Information and Medication Guide and discuss risks with their provider. Foundayo® may cause tumors in the thyroid, including thyroid cancer. Do not use if you or any family member has had medullary thyroid carcinoma (MTC), or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Common side effects include nausea, constipation, diarrhea, vomiting, indigestion, stomach pain, headache, and fatigue. Foundayo® may reduce the effectiveness of oral birth control pills, and providers may recommend alternative contraception for 30 days after starting and after each dose increase. This is not a complete list of side effects. See full Prescribing Information at foundayo.lilly.com. Foundayo® is a registered trademark of Eli Lilly and Company. Shed is not affiliated with or endorsed by Eli Lilly and Company.
*FSA/HSA eligibility depends on your individual plan. Please check with your plan administrator to confirm coverage before using your FSA/HSA card.
Compounded medications are not FDA-approved and are prepared by a licensed pharmacy based on a provider's prescription. A prescription is only issued after a consultation with a licensed provider who determines whether treatment is appropriate. Results may vary. Please refer to the Terms and Conditions for full details on the Shed weight-loss guarantee. In clinical trials of Wegovy® (2.4 mg), average weight loss was 15% and 20% when paired with diet and exercise.